CBDL (CBD Life Sciences) Market Cap: $1.78 Mil (As of Jun. 27, 2026)


What is CBD Life Sciences Market Cap?

CBD Life Sciences CBDL Market Cap is $1.78 Mil as of Jun. 27, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CBD Life Sciences's share price for the quarter that ended in Sep. 2015 was $92953.523238. CBD Life Sciences's Shares Outstanding (EOP) for the quarter that ended in Sep. 2015 was 0.00 Mil. Therefore, CBD Life Sciences's market cap for the quarter that ended in Sep. 2015 was $ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CBD Life Sciences's Enterprise Value for Today is $1.78 Mil.

CBD Life Sciences  (OTCPK:CBDL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

CBD Life Sciences Market Cap Related Terms

CBD Life Sciences Market Cap Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences Market Cap Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Market Cap
0.00 0.00 0.00 0.00

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBDL vs QPAG, ADGO, MCCX: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Market Cap distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Market Cap falls into.


CBD Life Sciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

CBD Life Sciences's Market Cap for the fiscal year that ended in Dec. 2014 is calculated as

Market Cap (A: Dec. 2014 )=Share Price (A: Dec. 2014 )*Shares Outstanding (EOP) (A: Dec. 2014 )
=$269865.067466*0
=$

CBD Life Sciences's Market Cap for the quarter that ended in Sep. 2015 is calculated as

Market Cap (Q: Sep. 2015 )=Share Price (Q: Sep. 2015 )*Shares Outstanding (EOP) (Q: Sep. 2015 )
=$92953.523238*0
=$

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $1.78 Mil mean?
CBD Life Sciences (CBDL) has a Market Cap of $1.78 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CBD Life Sciences and its competitors.
Is CBD Life Sciences' Market Cap too high?
CBD Life Sciences' current Market Cap is $1.78 Mil. The Drug Manufacturers industry median Market Cap is 205.37. CBD Life Sciences' value of $1.78 Mil is 99.1% below this industry median.
How does CBD Life Sciences' Market Cap compare to QPAG and ADGO?
CBD Life Sciences' Market Cap of $1.78 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 205.37. CBD Life Sciences' value of $1.78 Mil is 99.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 205.37, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CBD Life Sciences's current Market Cap of $1.78 Mil is 99.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CBD Life Sciences and its competitors. For the Drug Manufacturers industry, the median Market Cap is 205.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CBD Life Sciences's current Market Cap is $1.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current Market Cap of $1.78 Mil. The current Market Cap is $1.78 Mil and 99.1% below the Drug Manufacturers industry median of 205.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current Market Cap is $1.78 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.